The FDA has deemed the recall of the Medtronic (NYSE:MDT) Valiant Navion thoracic stent graft system as Class I, the most serious kind.
Medtronic’s Valiant Navion is designed to repair lesions of the descending thoracic aorta, using a long catheter to place the stent graft inside the aorta before it expands to fit within the aorta to provide a new path for blood to flow from the heart to the lower part of the body, according to an FDA release.
Get the full story at our sister site, Medical Tubing & Extrusion.